Orchidia Pharmaceutical Industries, based in El Obour City, Egypt, develops, manufactures and distributes pharmaceutical products.
Founded in 1993 and headquartered in El Obour City, Egypt, Orchidia Pharmaceutical Industries produces and distributes prescription medications, over-the-counter drugs and specialized formulations, mainly across the Middle East and North Africa. CEO Ossama Abbas and Rehab Gendy lead the team. In March 2026, a consortium led by SPE Capital, with EBRD, Proparco and BIO Invest, invested in the company; financial terms were not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in